Page last updated: 2024-11-04

sulfasalazine and T-Cell Lymphoma

sulfasalazine has been researched along with T-Cell Lymphoma in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yin, WH1
Zhang, HY1
Li, XF1
Ma, Y1

Other Studies

1 other study available for sulfasalazine and T-Cell Lymphoma

ArticleYear
[Drug-induced lymphadenitis].
    Zhonghua bing li xue za zhi = Chinese journal of pathology, 2010, Volume: 39, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; CD3 Complex; Colitis, Ulcerative; Diagnosis, Differe

2010